New ALS drug trial aims to slow nerve damage
Disease control
Recruiting now
This trial tests an experimental drug called NB-4746 in 80 people with ALS. The study has two parts: first, a short safety check with low or high doses, then a longer 12-week test. Researchers will watch for side effects, measure how the drug moves in the body, and check a blood …
Phase: PHASE1, PHASE2 • Sponsor: Nura Bio • Aim: Disease control
Last updated May 26, 2026 08:37 UTC